Bone marrow cells for cardiac regeneration and repair: Current status and issues

Expert Review of Cardiovascular Therapy

Volumn 4, Issue 4, 2006, Pages 557-568

  Haider, Husnain Kh ^a  

^a Department of Pathology and Laboratory of Medicine ^*  (United States)

Author keywords

Angiogenesis; Bone marrow; Heart; Infarction; Myocardium; Stem cells; Transplantation

Indexed keywords

ADENOVIRUS VECTOR; CYTOKINE; GLYCERYL TRINITRATE; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; GROWTH FACTOR; IMMUNOSUPPRESSIVE AGENT; VASCULOTROPIN; VASCULOTROPIN C;

ADJUVANT THERAPY; ANGIOGENESIS; BONE MARROW TRANSPLANTATION; CD34 SELECTION; CELL COUNT; CELL DEATH; CELL DIFFERENTIATION; CELL FUSION; CELL JUNCTION; CELL SURVIVAL; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; DNA MODIFICATION; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; EMBRYONIC STEM CELL; FOLLOW UP; GRAFT REJECTION; HEART ARRHYTHMIA; HEART DISEASE; HEART INFARCTION SIZE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART PERFUSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESOTHELIUM CELL; MONONUCLEAR CELL; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; PARACRINE SIGNALING; PHENOTYPE; PLURIPOTENT STEM CELL; PROCESS OPTIMIZATION; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; STEM CELL GENE THERAPY; STEM CELL MOBILIZATION; TISSUE REPAIR; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANTIGENS, CD34; ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; CORONARY ARTERY BYPASS; DISEASE MODELS, ANIMAL; HUMANS; MYOCYTES, CARDIAC; PHENOTYPE; REGENERATION; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33748103144     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.4.4.557     Document Type: Review

References (82)

1. Weissberg PL, Qasim A. Stem cell therapy for myocardial repair. Heart 91, 696-702 (2005).
2. Menasche P, Hagege AA, Scorsin M et al. Myoblast transplantation for heart failure. Lancet 357, 279-280 (2001).
3. Pagani FD, DerSimonian H, Zawadzka A et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J. Am. Coll. Cardiol. 41, 879-888 (2003).
4. Wollert KC, Meyer GP, Lotz J et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364, 141-148 (2004).
5. Chen SL, Fang WW, Ye F et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am. J. Cardiol 94, 92-95 (2004).
6. Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19, 180-192 (2001).
7. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res. 95, 9-20 (2004).
8. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41-49 (2002).
9. Nagaya N, Kangawa K, Itoh T et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112, 1128-1135 (2005).
10. Gojo S, Gojo N, Takeda Y et al. In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells. Exp. Cell. Res. 288, 51-59 (2003).
11. Wognum AW, Eaves AC, Thomas TE. Identification and isolation of hematopoietic stem cells. Arch. Med. Res. 34, 461-75 (2003).
12. Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell 116, 639-648 (2004).
13. Guo Y, Lubbert M, Engelhardt M. CD34- hematopoietic stem cells: current concepts and controversies. Stem Cells 21, 15-20 (2003).
14. Krause DS, Theise ND, Collector MI et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105, 369-377 (2001).
15. Jackson KA, Majka SM, Wang H et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 107, 1395-1402 (2001).
16. Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 410, 701-705 (2001).
17. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428, 668-673 (2004).
18. Nygren JM, Jovinge S, Breitbach M et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nature Med. 10, 494-501 (2004).
19. Deten A, Volz HC, Clamors S et al. Hematopoietic stem cells do not repair the infarcted mouse heart. Cardiovasc. Res. 65, 52-63 (2005).
20. Sahara M, Sata M, Matsuzaki Y et al. Comparison of various bone marrow fractions in the ability to participate in vascular remodeling after mechanical injury. Stem Cells 23, 874-878 (2005).
21. Rangappa S, Fen C, Lee EH, Bongso A, Sim EK. Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. Ann. Thorac. Surg. 75, 775-779 (2003).
22. Condorelli G, Borello U, De Angelis L et al. Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration. Proc. Natl Acad. Sci. USA 98, 10733-10738 (2001).
23. Fukuda K. Molecular characterization of regenerated cardiomyocytes derived from adult mesenchymal stem cells. Congenit. Anom. (Kyoto) 42, 1-9 (2002).
24. Hakuno D, Fukuda K, Makino S et al. Bone marrow-derived regenerated cardiomyocytes (CMG cells) express functional adrenergic and muscarinic receptors. Circulation 105, 380-386 (2002).
25. Liu Y, Song J, Liu W, Wanc Y, Chena X, Hua C. Growth and differentiation of rat bone marrow stromal cells: does 5-azacytidine trigger their cardiomyogenic differentiation? Cardiovasc. Res. 58, 460-468 (2003).
26. Limbourg FP, Ringes-Lichtenberg S, Schaefer A et al. Haematopoietic stem cells improve cardiac function after infarction without permanent cardiac engraftment. Eur. J. Heart. Fail. 7, 722-729 (2005).
27. Tang YL, Tang Y, Zhang YC, Qian K, Shen L, Phillips MI. Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J. Am. Coll. Cardiol. 46, 1339-1350 (2005).
28. Kawamoto A, Gwon HC, Iwaguro H et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103, 634-637 (2001).
29. Bel A, Messas E, Agbulut O et al. Transplantation of autologous fresh bone marrow into infarcted myocardium: a word of caution. Circulation 108(Suppl. 1), II247-II252 (2003).
30. Orlic D, Kajstura J, Chimenti S et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl Acad. Sci. USA 98, 10344-10349 (2001).
31. Ishida M, Tomita S, Nakatani T et al. Bone marrow mononuclear cell transplantation had beneficial effects on doxorubicin-induced cardiomyopathy. J. Heart Lung Transplant. 23, 436-445 (2004).
32. Shake JG, Gruber PJ, Baumgartner WA et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann. Thorac. Surg. 73, 1919-1925; discussion 1926 (2002).
33. Kudo M, Wang Y, Wani MA, Xu M, Ayub A, Ashraf M. Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart. J. Mol. Cell. Cardiol. 35, 1113-1119 (2003).
34. Murry CE, Soonpaa MH, Reinecke H et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428, 664-668 (2004).
35. Yoon YS, Park JS, Tkebuchava T, Luedeman C, Losordo DW. Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation 109, 3154-3157 (2004).
36. Wang JS, Shum-Tim D, Chedrawy E, Chiu RC. The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications. J. Thorac. Cardiovasc. Surg. 122, 699-705 (2001).
37. Li TS, Hayashi M, Liu ZL et al. Low angiogenic potency induced by the implantation of ex vivo expanded CD117(+) stem cells. Am J. Physiol. Heart Circ. Physiol. 286, H1236-H1241 (2004).
38. Lei Y, Haider H, Shujia J, Sim ES. Therapeutic angiogcnesis. Devising new strategies based on past experiences. Basic Res. Cardiol. 99, 121-132 (2004).
39. Kocher AA, Schuster MD, Szabolcs MJ et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7, 430-436 (2001).
40. Liu Y, Guoa J, Zhanga P et al. Bone marrow mononuclear cell transplantation into heart elevates the expression of angiogenic factors. Microvasc. Res. 25, 156-160 (2004).
41. Tang YL, Zhao, Q, Qin X et al. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann. Thorac. Surg. 80, 229-236; discussion 236-237 (2005).
42. Duan HF, Wu CT Wu DL et al. Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor. Mol. Ther. 8, 467-474 (2003).
43. Matsumoto R, Omura T, Yoshiyama M et al. Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 25, 1168-1173 (2005).
44. Kawamoto A, Murayama T, Kusano K et al. Synergistic effect of bone marrow mobilization and vascular endothelial growth factor-2 gene therapy in myocardial ischemia. Circulation 110, 1398-1405 (2004).
45. Strauer BE, Brehm M, Zeus T et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106, 1913-1918 (2002).
46. Assmus B, Schachinger V, Teupe C et al. Transplantation Of Progenitor Cells And Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) Circulation 106, 3009-3017 (2002).
47. Britten MB, Abolmaali ND, Assmus B et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 108, 2212-2228 (2003).
48. Tse HF, Kwong YL, Chan JK, Lo G, Ho CL, Lau CP. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361, 47-49 (2003).
49. Perin EC, Dohmann HF, Borojevic R et al. Transendocardial, autologous bone marrow Cell Transplant.ation for severe, chronic ischemic heart failure. Circulation 107, 2294-2302 (2003).
50. Perin EC, Dohmann HF, Borojevic R et al. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 110, II213-II218 (2004).
51. Fuchs S, Satler LF, Kornowski R et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. J. Am. Coll. Cardiol. 41, 1721-1724 (2003).
52. Stamm C, Westphal B, Kleine HD et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361, 45-46 (2003).
53. Stamm C, Kleine HD, Westphal B et al. CABG and bone marrow stem Cell Transplant.ation after myocardial infarction. Thorac. Cardiovasc. Surg. 52, 152-158 (2004).
54. Galinanes M, Loubani M, Davies J, Chin D, Pasi J, Bell PR. Autotransplantation of unmanipulated bone marrow into scarred myocardium is safe and enhances cardiac function in humans. Cell Transplant. 13, 7-13 (2004).
55. Yoo KJ, Kim HO, Kwak YL et al. Autologous bone marrow cell transplant.ation combined with off-pump coronary artery bypass grafting in human ischemic myocardium. Yonsei Med. J. 45(Suppl.), S73 (2004).
56. Fernandez-Aviles F, San Roman JA, Garcia-Frade J et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ. Res. 95, 742-748 (2004).
57. Bartunek J, Vanderheyden M, Vandekerckhove B et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 112, I178-I183 (2005).
58. Hamano K, Nishida M, Hirata K et al. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn Cirr. J. 65, 845-847 (2001).
59. Siminiak T, Grygielska B, Jerzykowska O et al. Autologous bone marrow stem Cell Transplant.ation in acute myocardial infarction-report of two cases. Kardiol. Pol. 59, 502-510 (2003).
60. Prosper F, Rabago G, Perez AA et al. Combined autologous myoblast transplantation with coronary revascularization in patients with non-acute myocardial infarction. J. Heart Lung Transplant. 23(2 Suppl. 1) S62 (2004).
61. Koutelou M, Theodorakos A, Kollaros N, Manginas A, Leontiadis E, Cokkinos, D. Assessment of cardiac sympathetic innervation in patients with heart failure after bone marrow cell transplantation. J. Nucl. Cardiol. 11, S30-S31 (2004).
62. Oakley RE, Msherqi ZA, Lim SK et al. Transplantation of autologous bone marrow-derived cells into the myocardium of patients undergoing coronary bypass. Heart Surg. Forum. 8, 348-350 (2005).
63. Blatt A, Cotter G, Leitman M et al. Intracoronary administration of autologous bone marrow mononuclear cells after induction of short ischemia is safe and may improve hibernation and ischemia in patients with ischemic cardiomyopathy. Am. Heart J. 150, 986 (2005).
64. Vulliet PR, Greeley M, Halloran SM, MacDonald KA, Kittleson MD. Intracoronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 363, 783-784 (2004).
65. Kang HJ, Kim HS, Zhang SY et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363, 751-756 (2004).
66. Chachques JC, Herreros J, Trainini J et al. Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int. J Cardiol. 95(1 Suppl.), S29-S33 (2004).
67. Skuk D, Caron N, Goulet M, Roy B, Espinosa F, Tremblay JP. Dynamics of the early immune cellular reactions after myogenic cell transplantation. Cell Transplant. 11, 671-681 (2002).
68. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105, 93-98 (2002).
69. Dai W, Hale SL, Martin BJ et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 112, 214-223 (2005).
70. Grinnemo KH, Mansson A, Dellgren G et al. Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. J. Thorac. Cardiovasc. Surg. 127, 1293-1300 (2004).
71. Haider H, Jiang SJ, Salim A et al. Transplantation of mesenchymal stem cells constitutively co-expressing akt and ang-1 leads to improved cardiac fimcdon in a rodent model of acute myocardial infarction. Circulation 112, II-I35 (2005).
72. Hodgetts SI, Grounds MD. Complement and myoblast transfer therapy: donor myoblast survival is enhanced following depletion of host complement C3 using cobra venom factor, but not in the absence of C5. Immunol. Cell Biol. 79, 231-239 (2001).
73. Camirand G, Caron NJ, Turgeon NA. Rossini AA, Tremblay JP Treatment with anti-CD154 antibody and donor-specific transfusion prevents acute rejection of myoblast transplantation. Transplantation 73, 453-461 (2002).
74. Mitchell PJ, Johnson SE, Hannon K. Insulin-like growth factor I stimulates myoblast expansion and myofiber development in the limb. Dev. Dyn. 223, 12-23 (2002).
75. Germani A, Di Carlo A, Mangoni A et al. Vascular endothelial growth factor modulates skeletal myoblast function. Am. J. Pathol. 163, 1417-1428 (2003).
76. Mangi AA, Noiseux N, Kong D et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 9, 1195-1201 (2003).
77. Scot EW. Stem cell plasticity or fusion: two approaches to the targeted cell therapy. Blood Cells Mol. Disease 32, 65-67 (2004).
78. Terada N, Hamazaki T, Oka M et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416, 542-545 (2002).
79. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425, 968-973 (2003).
80. Bayes-Genis A, Muniz-Diaz E, Catasus L et al. Cardiac chimerism in recipients of peripheral-blood and bone marrow stem cells. Eur. J. Heart. Fail 6, 399-402 (2004).
81. Adachi Y, Imagawa J, Suzuki Y et al. G-CSF treatment increases side population cell infiltration after myocardial infarction in mice. J. Mol. Cell. Cardiol. 36, 707-710 (2004).
82. Shintani S, Murohara T, Ikeda H et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103, 2776-2779 (2001).